JCRB2213 A9(Hygro13)
細胞情報
Important Notice(s)Information for the timing of selection for A9-series cell lines
ヒト単染色体導入ハイブリッド細胞の分譲について:鳥取大とのMTA締結が必要です
細胞種類:一般細胞 (細胞分譲手数料はこちら)
細胞番号(JCRB) | JCRB2213 | 細胞名 | A9(Hygro13) |
---|---|---|---|
生物種(日本語) | ヒト染色体導入株 | 組織名(日本語) | 単染色体導入パネル株 |
コメント(日本語) | ヒト13番染色体導入パネル細胞 (分譲には鳥取大とのMTAが必要) | プロフィール | contains human chromosome #13 (MTA with Tottori Univ. is required.) |
別名 | A9 | 動物名 | human chromosome-introduced |
系統名 | C3H | 学名・属名 | Mus |
種名 | musclus | 性別 | |
年齢・月齢 | 細胞識別情報 | ||
(癌)原発組織名 | human monochromosomal hybrid panel | 病歴情報 | |
転移の有無(Y/N) | (癌)転移組織名 | ||
遺伝的性質 | 94.7% cells included intact human chromosome #13 at deposit. | 細胞寿命 | infinite |
クライシスPDL | 形態 | fibroblast-like | |
一般性状 | skin fibroblast, AG-r. Cells include human chromosome #13. | 細胞分類 | panel |
細胞樹立者名 | Oshimura,M. | 細胞寄託者 | Oshimura,M. |
分譲時制限 | MTA with Tottori Univ. is required. | コメント | Human chromosome was selected by hygromycine B. |
入手年 | 1997 | 培養培地 | Dulbecco's modified Eagle's medium with 10% calf serum and 1mg/ml Hygromycin B (Sigma). |
継代方法 | Cells are treated with 0.25% trypsin. | 継代時細胞数 | 2 x 10^4 cells/ml |
人種 | 炭酸ガス濃度 | 5 % | |
採取組織名 | skin | 組織型 |
ウイルスDNA・RNA検出検査 (Detection of virus genome fragment by Real-time PCR) | |||||||||
---|---|---|---|---|---|---|---|---|---|
ウイルスDNA 検出検査 |
not tested | ウイルスRNA 検出検査 |
not tested |
Reference | |
---|---|
Pubmed id:10919723 | Human monochromosome hybrid cell panel characterized by FISH in the JCRB/HSRRB. Tanabe H,Nakagawa Y,Minegishi D,Hashimoto K,Tanaka N,Oshimura M,Sofuni T,Mizusawa H Chromosome Res. 2000;8(4):319-34 |
Pubmed id:8851764 | Cosmids and transcribed sequences from chromosome 11q23. Katoh M,Nakagawa Y,Yawata T,Kumano S,Kobayashi E,Kurimasa A,Kugoh H,Oshimura M Jpn J Hum Genet. 1995 Dec;40(4):307-17 |
Pubmed id:8527393 | Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Uejima H,Mitsuya K,Kugoh H,Horikawa I,Oshimura M Genes Chromosomes Cancer. 1995 Oct;14(2):120-7 |
Pubmed id:7493906 | Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Ohmura H,Tahara H,Suzuki M,Ide T,Shimizu M,Yoshida MA,Tahara E,Shay JW,Barrett JC,Oshimura M Jpn J Cancer Res. 1995 Oct;86(10):899-904 |
Pubmed id:1639397 | Ordering of human chromosome 3p markers by radiation hybrid mapping. Tamari M,Hamaguchi M,Shimizu M,Oshimura M,Takayama H,Kohno T,Yamaguchi N,Sugimura T,Terada M,Yokota J Genomics. 1992 Jul;13(3):705-12 |
Pubmed id:1723716 | Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1. Seya T,Okada M,Hara T,Matsumoto M,Miyagawa S,Oshimura M Immunology. 1991 Dec;74(4):719-24 |
Pubmed id:1995301 | Introduction of new genetic markers on human chromosomes. Satoh H,Barrett JC,Oshimura M Exp Cell Res. 1991 Mar;193(1):5-11 |
Pubmed id:1978855 | Establishment of a novel immortalized cell line from ataxia telangiectasia fibroblasts and its use for the chromosomal assignment of radiosensitivity gene. Ejima Y,Oshimura M,Sasaki MS Int J Radiat Biol. 1990 Dec;58(6):989-97 |
Pubmed id:2267132 | Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080. Kugoh HM,Hashiba H,Shimizu M,Oshimura M Oncogene. 1990 Nov;5(11):1637-44 |
Pubmed id:1702413 | Normal human chromosome 1 carries suppressor activity for various phenotypes of a Kirsten murine sarcoma virus-transformed NIH/3T3 cell line. Yamada H,Horikawa I,Hashiba H,Oshimura M Jpn J Cancer Res. 1990 Nov;81(11):1095-100 |
Pubmed id:2392323 | Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer. Yamada H,Wake N,Fujimoto S,Barrett JC,Oshimura M Oncogene. 1990 Aug;5(8):1141-7 |
Pubmed id:2502516 | Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Koi M,Shimizu M,Morita H,Yamada H,Oshimura M Jpn J Cancer Res. 1989 May;80(5):413-8 |
Pubmed id:2498246 | Construction of mouse A9 clones containing a single human chromosome (X/autosome translocation) via micro-cell fusion. Koi M,Morita H,Shimizu M,Oshimura M Jpn J Cancer Res. 1989 Feb;80(2):122-5 |
Pubmed id:14213660 | THREE DEGREES OF GUANYLIC ACID--INOSINIC ACID PYROPHOSPHORYLASE DEFICIENCY IN MOUSE FIBROBLASTS. LITTLEFIELD JW Nature. 1964 Sep 12;203():1142-4 |
Images |
---|
PDF File1 |
Movies |
---|
LOT Information
細胞番号 | JCRB2213 | 細胞名 | A9(Hygro13) |
---|---|---|---|
培養ロット番号 | 05202016 | 培養種別 | distribution |
培地 | Dulbecco's modified Eagle's medium with 10% calf serum and 1 mg/ml hygromycin B (Sigma). Hygromycin B should not be added immediately after thawing, but should be added after the cells start to grow. | 培養温度 | 37 C |
継代時細胞数(濃度) | approx. 1 x 10^5 cells/mL | 継代方法 | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
増殖速度 | approx. 30 hrs. | 凍結時生細胞濃度 | 5.0 x 10^6 |
凍結時生細胞率 | 91.0 | 使用抗生物質 | free |
継代数 | Unknown (9 at bank) | PDL数(プライマリ) | |
マイコプラズマ検出 | - | 細菌汚染検出 | - |
真菌汚染検出 | - | アイソザイム検査・動物名 | |
染色体モード | 染色体情報 | ||
表面抗原 | DNA Profile (STR) | ||
接着性 | Yes | 導入外部遺伝子 | |
凍結培地 | 10% DMSO, 20% CS - DMEM (without hygromycin B) | 炭酸ガス濃度 | 5% |
解凍後生細胞率 | 91.0 | 追加情報 |